Brett Haumann
2019
Compensation breakdown
| Non-Equity Incentive Plan | $170,000 |
|---|---|
| Salary | $543,047 |
| Stock Awards | $1,708,850 |
| Other | $42,382 |
| Total | $2,464,280 |
Haumann received $1.7M in stock awards, accounting for 69% of the total pay in 2019.
Haumann also received $170K in non-equity incentive plan, $543K in salary and $42.4K in other compensation.
Rankings
In 2019, Brett Haumann's compensation ranked 4,926th out of 13,971 executives tracked by ExecPay. In other words, Haumann earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,926 out of 13,971 | 65th |
Division Manufacturing | 1,833 out of 5,692 | 68th |
Major group Chemicals And Allied Products | 643 out of 2,189 | 71st |
Industry group Drugs | 543 out of 1,875 | 71st |
Industry Pharmaceutical Preparations | 406 out of 1,387 | 71st |
Pay ratio
| Brett Haumann's Pay | $2,464,280 |
|---|---|
| Median Employee's Pay | $219,765 |
| Pay Ratio | 11to 1 |
In 2019, the annual total compensation of Brett Haumann was $2,464,280.
The annual total compensation of the median employee at Theravance Biopharma was $219,765.
The ratio of Brett Haumann's pay to the pay of median employee was therefore 11 to one.
Haumann's colleagues
We found five more compensation records of executives who worked with Brett Haumann at Theravance Biopharma in 2019.
2019
Rick Winningham
Theravance Biopharma
Chief Executive Officer
2019
Andrew Hindman
Theravance Biopharma
Chief Financial Officer
2019
Bradford Shafer
Theravance Biopharma
General Counsel
2019
Frank Pasqualone
Theravance Biopharma
Senior Vice President and Chief Commercial Operations Officer
2019
Renee Gala
Theravance Biopharma
Chief Financial Officer
News
March 22, 2021
March 24, 2020
March 20, 2019